pI: 5.4315 |
Length (AA): 371 |
MW (Da): 41894 |
Paralog Number:
7
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_131104)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_50265 | Protein kinase domain containing protein |
Candida albicans | CaO19.5376 | Serine/threonine protein kinase |
Candida albicans | CaO19.3068 | DNA polymerase alpha suppressing protein kinase. |
Candida albicans | CaO19.12831 | Serine/threonine protein kinase |
Caenorhabditis elegans | CELE_Y59A8B.14 | Protein PAR-4, isoform B |
Dictyostelium discoideum | DDB_G0279629 | CAMKL family protein kinase |
Drosophila melanogaster | Dmel_CG9374 | CG9374 gene product from transcript CG9374-RE |
Homo sapiens | ENSG00000118046 | serine/threonine kinase 11 |
Loa Loa (eye worm) | LOAG_03149 | CAMK/CAMKL/LKB protein kinase |
Mus musculus | 20869 | serine/threonine kinase 11 |
Schmidtea mediterranea | mk4.002570.00 | Serine/threonine-protein kinase par-4 |
Trichomonas vaginalis | TVAG_319990 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_351980 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_374000 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_425830 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_032510 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_404110 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_192890 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_388270 | CAMK family protein kinase |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | serine/threonine kinase 11 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 30.3% | 175 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 22.9% | 310 aa | Compounds | References |
Xenopus laevis | Aurora kinase B-B | 368 aa | 27.2% | 302 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 23.0% | 309 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 27.4% | 237 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 26.8% | 310 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 25.3% | 293 aa | Compounds | References |
Rattus norvegicus | Jak1 protein | 210 aa | 22.8% | 202 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 24.5% | 306 aa | Compounds | References |